Revvity to Present at J.P. Morgan Healthcare Conference

Rhea-AI Summary

Revvity (NYSE: RVTY) has announced its participation in the 43rd annual J.P. Morgan Healthcare Conference scheduled for January 13, 2025, at 8:15 a.m. PT in San Francisco. President and CEO Prahlad Singh will present an update on the company's strategic priorities and overall direction. The presentation will be accessible through a live audio webcast, with a replay available on the Revvity Investor Relations website for a minimum of 30 days following the event.

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY) will present at the 43^rd annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 8:15 a.m. PT in San Francisco, CA.

President and Chief Executive Officer Prahlad Singh will provide an update on the Company and its strategic priorities.

To access the presentation, a live audio webcast will be available via this page. A replay of the presentation will be posted on the Revvity Investor Relations website after the event and will be available for at least 30 days.

About Revvity

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241217854213/en/

Investor Relations:

Steve Willoughby

steve.willoughby@revvity.com

Media Relations:

Chet Murray

(781) 462-5126

chet.murray@revvity.com

Source: Revvity

FAQ

When is Revvity (RVTY) presenting at the 2025 J.P. Morgan Healthcare Conference?

Revvity (RVTY) is scheduled to present on Monday, January 13, 2025, at 8:15 a.m. Pacific Time in San Francisco.

How can investors access Revvity's J.P. Morgan Healthcare Conference presentation?

Investors can access the presentation through a live audio webcast available on Revvity's website, with a replay accessible on the Revvity Investor Relations website for at least 30 days after the event.

What topics will be covered in Revvity's (RVTY) J.P. Morgan Healthcare Conference presentation?

President and CEO Prahlad Singh will provide updates on the company and discuss Revvity's strategic priorities.

How long will the replay of Revvity's (RVTY) J.P. Morgan Healthcare presentation be available?

The replay of the presentation will be available on Revvity's Investor Relations website for a minimum of 30 days after the event.